Showing results (11-20 of 545) with videos related to
Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directionsBrian I RiniClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2018
Goldilocks Dosing of TKIs: A Dose that Is Just Right Leads to Optimal OutcomesBrian I RiniNature Clinical Practice. Oncology|September 3, 2008
Lapatinib therapy for patients with advanced renal cell carcinomaBrian I RiniCancer|April 30, 2009
Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinomaBrian I RiniClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
The context of blood vessels and response to VEGF-targeted therapyBrian I RiniCancer|July 1, 2011
The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapyRobyn Macfarlane, Daniel Y C Heng, Wanling Xie, et al.Expert Opinion on Emerging Drugs|May 7, 2010
Emerging drugs for renal cell carcinomaLeticia Varella, Brian I RiniEuropean Urology Focus|April 18, 2025
Undertreatment or Overtreatment in the Adjuvant Setting for M1 No Evidence of Disease in Renal Cell Carcinoma: A Clinical ConundrumWesley Yip, Brian I RiniExpert Opinion on Emerging Drugs|October 4, 2016
Emerging growth factor receptor antagonists for the treatment of renal cell carcinomaHaris Zahoor, Brian I RiniClinical Genitourinary Cancer|January 24, 2007
Therapeutic considerations in patients with metastatic renal cell carcinoma previously treated with antiangiogenic therapiesSaby George, Brian I RiniPageof 55